Advanced search
Publication Cover
Modern Rheumatology Volume 22, 2012 - Issue 6
Journal homepage
139
Views
39
CrossRef citations to date
0
Altmetric
Original Article

Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors

Michi TanakaDepartment of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan;Department of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
,
Ryoko SakaiDepartment of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
,
Ryuji KoikeDepartment of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan;Department of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan;Clinical Research Center, Tokyo Medical and Dental University Hospital, Tokyo, Japan
,
Yukiko KomanoDepartment of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
,
Toshihiro NankiDepartment of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan;Department of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
,
Fumikazu SakaiDepartment of Diagnostic Radiology, International Medical Center, Saitama Medical University, Saitama, Japan
,
Haruhito SugiyamaNational Center for Global Health and Medicine, Tokyo, Japan
,
Hidekazu MatsushimaSaitama Red Cross Hospital, Saitama, Japan
,
Toshihisa KojimaDepartment of Orthopedic Surgery, Nagoya University School of Medicine, Nagoya, Japan
,
Shuji OhtaHitachi Ltd., Taga General Hospital, Hitachi, Japan
,
Yoji IshibeSaijo Central Hospital, Saijo, Japan
,
Takuya SawabeHiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, Japan
,
Yasuhiro OtaYasuhiro Clinic, Hamamatsu, Japan
,
Kazuhisa OhishiHamamatsu Medical Center, Hamamatsu, Japan
,
Hajime MiyazatoShunan Memorial Hospital, Yamaguchi, Japan
,
Yoshinori NonomuraDepartment of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
,
Kazuyoshi SaitoThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
,
Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
,
Hayato NagasawaDepartment of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Saitama, Japan
,
Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University, Tokyo, Japan
,
Ayako NakajimaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
,
Hideo OhtsuboJapanese Red Cross Society Kagoshima Hospital, Kagoshima, Japan
,
Makoto OnishiCenter for Rheumatic Disease, Dohogo Spa Hospital, Matsuyama, Japan
,
Yoshinori GotoGoto Medical Clinic, Hamamatsu, Japan
,
Hiroaki DobashiDivision of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Kagawa, Japan
,
Nobuyuki MiyasakaDepartment of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
&
Masayoshi HarigaiDepartment of Pharmacovigilance, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan;Department of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, JapanCorrespondence[email protected]
 show all
Pages 849-858 | Received 11 Jan 2012, Accepted 01 Feb 2012, Published online: 02 Jan 2014

Citations (39)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Takahiro Nunokawa, Naoto Yokogawa, Kota Shimada & Shoji Sugii. (2019) Effect of sulfasalazine use on the presence of Pneumocystis organisms in the lung among patients with rheumatoid arthritis: A test-negative design case–control study with PCR tests. Modern Rheumatology 29:3, pages 436-440.
Read now
Eri Sato, Eiichi Tanaka, Moeko Ochiai, Yoko Shimizu, Akiko Kobayashi, Kumi Shidara, Daisuke Hoshi, Naoki Sugimoto, Eisuke Inoue, Yohei Seto, Ayako Nakajima, Atsuo Taniguchi, Shigeki Momohara & Hisashi Yamanaka. (2015) Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012. Modern Rheumatology 25:3, pages 350-357.
Read now
Takao Koike, Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Syuji Takei, Tsutomu Takeuchi, Hisashi Yamanaka, Shigenori Haruna, Naoko Ushida, Katsuyoshi Kawana & Yoshiya Tanaka. (2014) Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients. Modern Rheumatology 24:3, pages 390-398.
Read now

Articles from other publishers (36)

Anji Xiong, Wenxuan Luo, Xiaoyu Tang, Yuzi Cao, Qilang Xiang, Ruiting Deng & Shiquan Shuai. (2023) Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis. Seminars in Arthritis and Rheumatism 63, pages 152257.
Crossref
Kohei Miyake, Tetsuji Kawamura, Yasuharu Nakahara & Shin Sasaki. (2023) A single-center, person-month-based analysis of the risk of developing Pneumocystis pneumonia (PCP) in immunosuppressed non-HIV patients: Preventive effects of trimethoprim-sulfamethoxazole. Journal of Infection and Chemotherapy 29:12, pages 1097-1102.
Crossref
Ting Xue, Xiaomei Kong & Liang Ma. (2023) Trends in the Epidemiology of Pneumocystis Pneumonia in Immunocompromised Patients without HIV Infection. Journal of Fungi 9:8, pages 812.
Crossref
Daniel Clemente Garulo, Esmeralda Núñez-Cuadros, Marisol Camacho Lovillo, Joan Calzada-Hernández, Sara Guillén Martín, Laura Fernández Silveira, María José Lirola Cruz, Alfredo Tagarro, Rosa María Alcobendas Rueda, Agustín López López, Miren Satrustegi Aritziturri & Cristina Calvo. (2023) Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis. European Journal of Pediatrics.
Crossref
Hideyuki Shiba, Takuya Kotani, Koji Nagai, Kenichiro Hata, Wataru Yamamoto, Ayaka Yoshikawa, Yumiko Wada, Yuri Hiramatsu, Hidehiko Makino, Yo Ueda, Akira Onishi, Koichi Murata, Hideki Amuro, Yonsu Son, Ryota Hara, Toru Hirano, Kosuke Ebina, Masaki Katayama, Motomu Hashimoto & Tohru Takeuchi. (2023) Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by Pneumocystis jirovecii Pneumonia and One-Year Clinical Course: The ANSWER Cohort Study. International Journal of Molecular Sciences 24:8, pages 7399.
Crossref
Jun Li, Suli Wang, Jiayi Zheng, Qianqian Li, Jia Li & Liangjing Lu. (2022) Clinical characteristics of and risk factors for Pneumocystis jirovecii pneumonia in anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody-positive dermatomyositis patients: a single-center retrospective study. Clinical Rheumatology 42:2, pages 453-462.
Crossref
H. Dele Davies. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases 674 678.e3 .
Ryan Ha, Yoav Keynan & Zulma Vanessa Rueda. (2022) Increased susceptibility to pneumonia due to tumour necrosis factor inhibition and prospective immune system rescue via immunotherapy. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Shin-ichiro Ohmura, Yoichiro Homma, Takayuki Masui & Toshiaki Miyamoto. (2022) Factors Associated with <i>Pneumocystis jirovecii</i> Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study. Internal Medicine 61:7, pages 997-1006.
Crossref
Amine Ghembaza, Mathieu Vautier, Patrice Cacoub, Valérie Pourcher & David Saadoun. (2020) Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases. Chest 158:6, pages 2323-2332.
Crossref
Sandra Rodríguez, Andrés Muñoz, Rosa-Helena Bustos & Diego Jaimes. (2020) Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview. Biomedicines 8:9, pages 303.
Crossref
Joshua S. Davis, David Ferreira, Emma Paige, Craig Gedye & Michael Boyle. (2020) Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clinical Microbiology Reviews 33:3.
Crossref
César Arturo  Nava-Valdivia, Juan Manuel  Ponce-Guarneros, Gustavo Echeverría-González, Elsa Janneth  Anaya-Ambriz, Juan José  Rubio-Castro, Axel Torres-Monarrez, Diana Lucero  Muñoz-Montes de Oca & Gabriel Cruz-López. (2020) Infecciones asociadas al uso de fármacos anti-TNF en enfermedades reumáticas. El Residente 15:1, pages 12-18.
Crossref
Ioanna Petta, Isabelle Peene, Dirk Elewaut, Lars Vereecke & Karolien De Bosscher. (2019) Risks and benefits of corticosteroids in arthritic diseases in the clinic. Biochemical Pharmacology 165, pages 112-125.
Crossref
Beatriz P. Braga, Sergio Prieto-González & José Hernández-Rodríguez. (2019) Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases. Medicina Clínica 152:12, pages 502-507.
Crossref
Beatriz P. Braga, Sergio Prieto-González & José Hernández-Rodríguez. (2019) Pneumocystis jirovecii pneumonia prophylaxis in immunocompromised patients with systemic autoimmune diseases. Medicina Clínica (English Edition) 152:12, pages 502-507.
Crossref
Shin-ichiro Ohmura, Taio Naniwa, Shin-ya Tamechika, Toshiaki Miyamoto, Daisuke Shichi, Nobukata Kazawa, Shiho Iwagaitsu, Shinji Maeda, Jun-ichi Wada & Akio Niimi. (2019) Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study. Journal of Infection and Chemotherapy 25:4, pages 253-261.
Crossref
Takahiro Nunokawa, Naoto Yokogawa, Kota Shimada, Shoji Sugii, Jinju Nishino, Masahiko Gosho, Yukiko Wagatsuma & Shigeto Tohma. (2019) Prophylactic effect of sulfasalazine against Pneumocystis pneumonia in patients with rheumatoid arthritis: A nested case-control study. Seminars in Arthritis and Rheumatism 48:4, pages 573-578.
Crossref
Kazutoshi Yukawa, Yasutsugu Nagamoto, Hirofumi Watanabe, Masamoto Funaki, Mitsuhiro Iwahashi, Jiro Yamana, Rie Sasaki & Seizo Yamana. (2018) Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Rheumatoid Arthritis and a Prophylactic Indication of Trimethoprim/Sulfamethoxazole. JCR: Journal of Clinical Rheumatology 24:7, pages 355-360.
Crossref
Kay Frances Graham & Anne McEntegart. (2018) Pneumocystis jiroveci pneumonia in a patient taking Benepali for rheumatoid arthritis . BMJ Case Reports, pages bcr-2018-224764.
Crossref
H. Dele Davies. 2018. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases 651 656.e3 .
Fumikazu Sakai. 2018. Drug-Induced Lung Injury. Drug-Induced Lung Injury 59 81 .
Masako Utsunomiya, Hiroaki Dobashi, Toshio Odani, Kazuyoshi Saito, Naoto Yokogawa, Kenji Nagasaka, Kenchi Takenaka, Makoto Soejima, Takahiko Sugihara, Hiroyuki Hagiyama, Shinya Hirata, Kazuo Matsui, Yoshinori Nonomura, Masahiro Kondo, Fumihito Suzuki, Makoto Tomita, Mari Kihara, Waka Yokoyama, Fumio Hirano, Hayato Yamazaki, Ryoko Sakai, Toshihiro Nanki, Ryuji Koike, Hitoshi Kohsaka, Nobuyuki Miyasaka & Masayoshi Harigai. (2017) Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial. Arthritis Research & Therapy 19:1.
Crossref
Daisuke IKUMA, Kazuhiro YOKOTA, Kojiro SATO & Toshihide MIMURA. (2017) A case of new-onset rheumatoid vasculitis becoming evident in the course of treatment for <i>Pneumocystis jirovecii</i> pneumonia. Japanese Journal of Clinical Immunology 40:1, pages 78-82.
Crossref
H. Dele Davies, Carrie L. Byington, Yvonne A. Maldonado, Elizabeth D. Barnett, Kathryn M. Edwards, Ruth Lynfield, Flor M. Munoz-Rivas, Dawn L. Nolt, Ann-Christine Nyquist, Mobeen H. Rathore, Mark H. Sawyer, William J. Steinbach, Tina Q. Tan & Theoklis E. Zaoutis. (2016) Infectious Complications With the Use of Biologic Response Modifiers in Infants and Children. Pediatrics 138:2.
Crossref
Jun Nakamura, Takao Nagashima, Katsuya Nagatani, Taku Yoshio, Masahiro Iwamoto & Seiji Minota. (2016) Reactivation of hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs. International Journal of Rheumatic Diseases 19:5, pages 470-475.
Crossref
Noboru Takayanagi,. (2015) Biological agents and respiratory infections: Causative mechanisms and practice management. Respiratory Investigation 53:5, pages 185-200.
Crossref
Melanie T. Cushion. 2015. Manual of Clinical Microbiology . Manual of Clinical Microbiology 2015 2029 .
Takahiko Sugihara, Tatsuro Ishizaki, Tadashi Hosoya, Shoko Iga, Waka Yokoyama, Fumio Hirano, Nobuyuki Miyasaka & Masayoshi Harigai. (2015) Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE). Rheumatology 54:5, pages 798-807.
Crossref
Despoina Papadopoulou, Christos Tsoulas, Athanassios Tragiannidis & Nikolaos V. Sipsas. (2015) Role of vaccinations and prophylaxis in rheumatic diseases. Best Practice & Research Clinical Rheumatology 29:2, pages 306-318.
Crossref
Shunsuke MoriMineharu Sugimoto. (2015) Pneumocystis Jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations . Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23286.
Crossref
Raquel Faria, Cláudia Pereira, Rute Alves, Teresa Mendonça, Fátima Farinha & Carlos Vasconcelos. 2015. Infection and Autoimmunity. Infection and Autoimmunity 251 277 .
Toshiaki Kogure, Naoyuki Harada, Takeshi Tatsumi & Hiroshi Fujinaga. (2014) Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis. Clinical Rheumatology 33:3, pages 323-328.
Crossref
Takayuki Katsuyama, Kazuyoshi Saito, Satoshi Kubo, Masao Nawata & Yoshiya Tanaka. (2014) Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study. Arthritis Research & Therapy 16:1, pages R43.
Crossref
Kiyoshi Migita, Toru Arai, Naoki Ishizuka, Yuka Jiuchi, Yasuharu Sasaki, Yasumori Izumi, Tetsuyuki Kiyokawa, Eiichi Suematsu, Tomoya Miyamura, Hiroshi Tsutani, Yojiro Kawabe, Ryutaro Matsumura, Shunsuke Mori, Shiro Ohshima, Shigeru Yoshizawa, Kenji Kawakami, Yasuo Suenaga, Hideo Nishimura, Toyohiko Sugimoto, Hiroaki Iwase, Hideyuki Sawada, Haruhiro Yamashita, Shigeyuki Kuratsu, Fumitaka Ogushi, Masaharu Kawabata, Toshihiro Matsui, Hiroshi Furukawa, Seiji Bito & Shigeto Tohma. (2013) Rates of Serious Intracellular Infections in Autoimmune Disease Patients Receiving Initial Glucocorticoid Therapy. PLoS ONE 8:11, pages e78699.
Crossref
Jun Li, Suli Wang, Qianqian Li, Jiayi Zheng, Jia Li & Liangjing Lu. (2021) Clinical Characteristics and Risk Factors of Pneumocystis Jirovecii Pneumonia in Anti-Melanoma Differentiation Associated Gene 5 (Anti-MDA5) Antibody-Positive Dermatomyositis: A Single Center Retrospective Study. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.